Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hanlon

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Global Heart|September 16, 2024
A Cross-Sectional Survey of Fixed-Dose Combination Antihypertensive Medicine Prescribing in Twenty-Four Countries, Including Qualitative InsightsEdel O'Hagan, Daniel McIntyre, Tu Nguyen, et al.
Ageing Research Reviews|October 5, 2023
Recent developments in frailty identification, management, risk factors and prevention: A narrative review of leading journals in geriatrics and gerontologyElsa Dent, Peter Hanlon, Marc Sim, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 9, 2024
Sex differences in cancer outcomes across the range of eGFRRichard Shemilt, Michael K Sullivan, Peter Hanlon, et al.
BMJ Open|October 27, 2022
Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocolElaine Butterly, Lili Wei, Amanda I Adler, et al.
Endocrinology, Diabetes & Metabolism|September 10, 2021
Family history of diabetes and risk of SARS-COV-2 in UK Biobank: A prospective cohort studyBhautesh Dinesh Jani, Barbara I Nicholl, Peter Hanlon, et al.
BMC Medicine|November 10, 2020
Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK BiobankFanny Petermann-Rocha, Peter Hanlon, Stuart R Gray, et al.
BMC Medicine|April 10, 2026
Interventions to prevent and treat multiple long-term conditions and their consequences across the life course: concepts and definitionsMiles D Witham, Guruprasad P Aithal, Michelle Collinson, et al.
JAMA|February 3, 2025
Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-AnalysisPeter Hanlon, Elaine Butterly, Lili Wei, et al.
BMC Medicine|January 8, 2025
Multimorbidity clusters and their associations with health-related quality of life in two UK cohortsLewis Steell, Stefanie J Krauth, Sayem Ahmed, et al.
Eclinicalmedicine|July 24, 2024
Association of latent class analysis-derived multimorbidity clusters with adverse health outcomes in patients with multiple long-term conditions: comparative results across three UK cohortsStefanie J Krauth, Lewis Steell, Sayem Ahmed, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Global Heart|September 16, 2024
A Cross-Sectional Survey of Fixed-Dose Combination Antihypertensive Medicine Prescribing in Twenty-Four Countries, Including Qualitative InsightsEdel O'Hagan, Daniel McIntyre, Tu Nguyen, et al.
Ageing Research Reviews|October 5, 2023
Recent developments in frailty identification, management, risk factors and prevention: A narrative review of leading journals in geriatrics and gerontologyElsa Dent, Peter Hanlon, Marc Sim, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 9, 2024
Sex differences in cancer outcomes across the range of eGFRRichard Shemilt, Michael K Sullivan, Peter Hanlon, et al.
BMJ Open|October 27, 2022
Calibrating a network meta-analysis of diabetes trials of sodium glucose cotransporter 2 inhibitors, glucagon-like peptide-1 receptor analogues and dipeptidyl peptidase-4 inhibitors to a representative routine population: a systematic review protocolElaine Butterly, Lili Wei, Amanda I Adler, et al.
Endocrinology, Diabetes & Metabolism|September 10, 2021
Family history of diabetes and risk of SARS-COV-2 in UK Biobank: A prospective cohort studyBhautesh Dinesh Jani, Barbara I Nicholl, Peter Hanlon, et al.
BMC Medicine|November 10, 2020
Comparison of two different frailty measurements and risk of hospitalisation or death from COVID-19: findings from UK BiobankFanny Petermann-Rocha, Peter Hanlon, Stuart R Gray, et al.
BMC Medicine|April 10, 2026
Interventions to prevent and treat multiple long-term conditions and their consequences across the life course: concepts and definitionsMiles D Witham, Guruprasad P Aithal, Michelle Collinson, et al.
JAMA|February 3, 2025
Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-AnalysisPeter Hanlon, Elaine Butterly, Lili Wei, et al.
BMC Medicine|January 8, 2025
Multimorbidity clusters and their associations with health-related quality of life in two UK cohortsLewis Steell, Stefanie J Krauth, Sayem Ahmed, et al.
Eclinicalmedicine|July 24, 2024
Association of latent class analysis-derived multimorbidity clusters with adverse health outcomes in patients with multiple long-term conditions: comparative results across three UK cohortsStefanie J Krauth, Lewis Steell, Sayem Ahmed, et al.
Pageof 9